Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet

Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet

The drug is used to treat psychotic disorders such as schizophrenia

FPJ Web DeskUpdated: Tuesday, January 10, 2023, 04:01 PM IST
article-image
Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet | Image: Ajanta Pharma (Representative)

Ajanta Pharma Ltd has received an approval from the US Food and Drug Administration (USFDA) for Fluphenazine Hydrochloride tablet, as per an exchange filing.

The dosage is in 1 mg, 2.5 mg, 5 mg and 10 mg strengths, according to an update on the drug regulator's website.

The drug is used to treat psychotic disorders such as schizophrenia.

RECENT STORIES

Gautam Adani Joins Puri's Shree Jagannath Rath Yatra 2025, Adani Group Launches Massive 'Prasad...

Gautam Adani Joins Puri's Shree Jagannath Rath Yatra 2025, Adani Group Launches Massive 'Prasad...

LG Eyes Space Industry Entry, Unveils Ambitious Lunar Landing Goal by 2032

LG Eyes Space Industry Entry, Unveils Ambitious Lunar Landing Goal by 2032

Meesho Receives Shareholder Approval To Launch IPO; $500 Million In Fresh Capital

Meesho Receives Shareholder Approval To Launch IPO; $500 Million In Fresh Capital

India & Bangladesh Conflict: India Bans Jute Imports & Woven Fabrics

India & Bangladesh Conflict: India Bans Jute Imports & Woven Fabrics

Can’t Wait For iPhone 17? These 5 Flagship Smartphones Launching Before September Might Be Better...

Can’t Wait For iPhone 17? These 5 Flagship Smartphones Launching Before September Might Be Better...